Platelet Function Monitoring in Patients Treated With Clopidogrel at the Time of Primary Percutaneous Coronary Angioplasty

NCT00827346 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Platelet Reactivity

Interventions

DRUG: Clopidogrel
DRUG: Clopidogrel
DRUG: Clopidogrel
DRUG: Clopidogrel

Sponsor

Ottawa Heart Institute Research Corporation